AMA
Akbarizadeh M, Naderifar M, Ghanizadegan P, Akbarizadeh M. Ketoacidosis as a primary manifestation of COVID-19. Pediatric Endocrinology Diabetes and Metabolism. 2021;27(2):146-148. doi:10.5114/pedm.2021.105299.
APA
Akbarizadeh, M., Naderifar, M., Ghanizadegan, P., & Akbarizadeh, M. (2021). Ketoacidosis as a primary manifestation of COVID-19. Pediatric Endocrinology Diabetes and Metabolism, 27(2), 146-148. https://doi.org/10.5114/pedm.2021.105299
Chicago
Akbarizadeh, Majidreza, Mahin Naderifar, Parisa Ghanizadegan, and Mahshid Akbarizadeh. 2021. "Ketoacidosis as a primary manifestation of COVID-19". Pediatric Endocrinology Diabetes and Metabolism 27 (2): 146-148. doi:10.5114/pedm.2021.105299.
Harvard
Akbarizadeh, M., Naderifar, M., Ghanizadegan, P., and Akbarizadeh, M. (2021). Ketoacidosis as a primary manifestation of COVID-19. Pediatric Endocrinology Diabetes and Metabolism, 27(2), pp.146-148. https://doi.org/10.5114/pedm.2021.105299
MLA
Akbarizadeh, Majidreza et al. "Ketoacidosis as a primary manifestation of COVID-19." Pediatric Endocrinology Diabetes and Metabolism, vol. 27, no. 2, 2021, pp. 146-148. doi:10.5114/pedm.2021.105299.
Vancouver
Akbarizadeh M, Naderifar M, Ghanizadegan P, Akbarizadeh M. Ketoacidosis as a primary manifestation of COVID-19. Pediatric Endocrinology Diabetes and Metabolism. 2021;27(2):146-148. doi:10.5114/pedm.2021.105299.
